154 related articles for article (PubMed ID: 30898394)
21. Overexpression of pim-3 and protective role in lipopolysaccharide-stimulated hepatic stellate cells.
Liu LH; Lai QN; Chen JY; Zhang JX; Cheng B
World J Gastroenterol; 2015 Aug; 21(29):8858-67. PubMed ID: 26269675
[TBL] [Abstract][Full Text] [Related]
22. Effects of PIM3 in prognosis of colon cancer.
Zhou Y; Zhou YN; Liu SX; Wang J; Ji R; Yan X
Clin Transl Oncol; 2021 Oct; 23(10):2163-2170. PubMed ID: 33928496
[TBL] [Abstract][Full Text] [Related]
23. The serine-threonine kinase PIM3 is an aldosterone-regulated protein in the distal nephron.
Spirli A; Cheval L; Debonneville A; Penton D; Ronzaud C; Maillard M; Doucet A; Loffing J; Staub O
Physiol Rep; 2019 Aug; 7(15):e14177. PubMed ID: 31397090
[TBL] [Abstract][Full Text] [Related]
24. Proto-Oncogene Serine/Threonine Kinase PIM3 Promotes Cell Migration via Modulating Rho GTPase Signaling.
Dang Y; Jiang N; Wang H; Chen X; Gao Y; Zhang X; Qin G; Li Y; Chen R
J Proteome Res; 2020 Mar; 19(3):1298-1309. PubMed ID: 31994402
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas.
Kim H; Ham EK; Kim YI; Chi JG; Lee HS; Park SH; Jung YM; Myung NK; Lee MJ; Jang JJ
Cancer Lett; 1998 Sep; 131(2):177-83. PubMed ID: 9851251
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
28. PIM3 Kinase: A Promising Novel Target in Solid Cancers.
Atalay P; Ozpolat B
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339286
[TBL] [Abstract][Full Text] [Related]
29. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma.
Saida S; Watanabe K; Kato I; Fujino H; Umeda K; Okamoto S; Uemoto S; Hishiki T; Yoshida H; Tanaka S; Adachi S; Niwa A; Nakahata T; Heike T
Pediatr Int; 2015 Aug; 57(4):558-66. PubMed ID: 25682862
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol regulates cell proliferation and apoptosis of colorectal cancer by modulating miR-33a-PIM3 pathway.
Wang Y; Liu C; Hu L
Biochem Biophys Res Commun; 2019 Apr; 511(3):685-692. PubMed ID: 30827510
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA-CRNDE: a novel regulator of tumor growth and angiogenesis in hepatoblastoma.
Dong R; Liu XQ; Zhang BB; Liu BH; Zheng S; Dong KR
Oncotarget; 2017 Jun; 8(26):42087-42097. PubMed ID: 28178668
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
35. PIM kinases as therapeutic targets against advanced melanoma.
Shannan B; Watters A; Chen Q; Mollin S; Dörr M; Meggers E; Xu X; Gimotty PA; Perego M; Li L; Benci J; Krepler C; Brafford P; Zhang J; Wei Z; Zhang G; Liu Q; Yin X; Nathanson KL; Herlyn M; Vultur A
Oncotarget; 2016 Aug; 7(34):54897-54912. PubMed ID: 27448973
[TBL] [Abstract][Full Text] [Related]
36. Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival.
Schmidt A; Armento A; Bussolati O; Chiu M; Ellerkamp V; Scharpf MO; Sander P; Schmid E; Warmann SW; Fuchs J
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3169-3181. PubMed ID: 34235580
[TBL] [Abstract][Full Text] [Related]
37. Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma.
Dong R; Liu GB; Liu BH; Chen G; Li K; Zheng S; Dong KR
Cell Death Dis; 2016 Jun; 7(6):e2278. PubMed ID: 27362796
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of an in vivo-efficacious PIM3 kinase inhibitor as a candidate anti-pancreatic cancer agent.
Nakano H; Hasegawa T; Saito N; Furukawa K; Mukaida N; Kojima H; Okabe T; Nagano T
Bioorg Med Chem Lett; 2015 Dec; 25(24):5687-93. PubMed ID: 26547690
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
